High hepatic first-pass metabolism is seen in all EXCEPT
## Core Concept
The hepatic first-pass effect refers to the rapid metabolism of a drug after it has been absorbed from the gastrointestinal tract and before it reaches systemic circulation. This occurs because the drug is initially transported to the liver via the hepatic portal vein, where it is metabolized by liver enzymes, primarily **cytochrome P450**, before it can reach the rest of the body.
## Why the Correct Answer is Right
The correct answer, , likely represents a drug or a characteristic that does not undergo significant hepatic first-pass metabolism. Drugs that are not significantly metabolized by the liver before reaching systemic circulation often have higher bioavailability. This could be due to several factors, including the route of administration (e.g., intravenous, which bypasses the liver initially), chemical stability, or specific physicochemical properties that protect them from rapid hepatic metabolism.
## Why Each Wrong Option is Incorrect
* **Option A:** likely represents a drug or characteristic associated with high hepatic first-pass metabolism. Drugs administered orally and have high lipophilicity or are substrates for certain liver enzymes are more prone to extensive first-pass metabolism.
* **Option B:** similarly, this option probably represents another drug or characteristic that results in significant first-pass metabolism, necessitating higher doses to achieve therapeutic effects systemically.
* **Option C:** this option also likely undergoes substantial hepatic first-pass metabolism, which is a critical consideration in the design of dosing regimens for such drugs.
## Clinical Pearl / High-Yield Fact
A key clinical pearl is that drugs with high first-pass metabolism must be administered in higher doses orally to achieve therapeutic systemic levels. Conversely, **sublingual or transdermal routes** can sometimes be used to bypass first-pass metabolism. For example, nitroglycerin is often given sublingually to rapidly achieve therapeutic effects while minimizing first-pass metabolism.
## Correct Answer: D.